The effect of PDE5 Inhibitors on the male reproductive tract

The therapeutic range of cyclic nucleotide phosphodiesterase 5 inhibitors (PDE5) inhibitors is getting wider in the last years. This review study focuses on the potential employment of PDE5 inhibitors as an adjunct tool for the therapeutic management of male infertility. The literature tends to sugg...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofikitis, Nikolaos (Author) , Kaltsas, Aris (Author) , Dimitriadis, Fotios (Author) , Rassweiler, Jens (Author) , Grivas, Nikolaos (Author) , Zachariou, Athanasios (Author) , Kaponis, Apostolos (Author) , Tsounapi, Panagiota (Author) , Paterakis, Napoleon (Author) , Karagiannis, Andreas (Author) , Skouros, Sotirios (Author) , Giannakis, Ioannis (Author) , Champilomatis, Ioannis (Author) , Paschopoulos, Minas (Author) , Daphnis, Diamantis (Author) , Giakoumakis, Ioannis (Author) , R. Gabales, Melinda (Author) , Chua, Jo Ben M. (Author) , Lantin, Pedro L. Lantin (Author) , Mamoulakis, Charalampos (Author) , Takenaka, Atsushi (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Current pharmaceutical design
Year: 2021, Volume: 27, Issue: 23, Pages: 2697-2713
ISSN:1873-4286
DOI:10.2174/1381612826666200226121510
Online Access:lizenzpflichtig
lizenzpflichtig
Get full text
Author Notes:Nikolaos Sofikitis, Aris Kaltsas, Fotios Dimitriadis, Jens Rassweiler, Nikolaos Grivas, Athanasios Zachariou, Apostolos Kaponis, Panagiota Tsounapi, Napoleon Paterakis, Andreas Karagiannis, Sotirios Skouros, Ioannis Giannakis, Ioannis Champilomatis, Minas Paschopoulos, Diamantis Daphnis, Ioannis Giakoumakis, Melinda R. Gabales, Jo Ben M. Chua, Pedro L. Lantin Lantin, Charalampos Mamoulakis and Atsushi Takenaka
Description
Summary:The therapeutic range of cyclic nucleotide phosphodiesterase 5 inhibitors (PDE5) inhibitors is getting wider in the last years. This review study focuses on the potential employment of PDE5 inhibitors as an adjunct tool for the therapeutic management of male infertility. The literature tends to suggest a beneficial effect of PDE5 inhibitors on Leydig and Sertoli cells secretory function. It also appears that PDE5 inhibitors play a role in the regulation of the contractility of the testicular tunica albuginea and the epididymis. Moreover, scientific data suggest that PDE5 inhibitors enhance the prostatic secretory function leading to an improvement in sperm motility. Other studies additionally demonstrate the role of PDE5 inhibitors in the regulation of the sperm capacitation process. Placebo-controlled, randomized, blind studies are necessary to unambiguously incorporate PDE5 inhibitors as an adjunct tool for the pharmaceutical treatment of semen disorders and male infertility.
Item Description:First online: 26 February, 2020
Gesehen am 12.05.2022
Physical Description:Online Resource
ISSN:1873-4286
DOI:10.2174/1381612826666200226121510